Consensus Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Market Closed - London S.E. Other stock markets 09:05:16 10/05/2024 pm IST			5-day change	1st Jan Change
39 ^GBX	+2.63%		+4.00%	-6.02%

30/04	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
30/04	Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Evolution of the average Target Price on Beximco Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

b570eca4cd857c96c1c5e6015fb68c.3X_1p96zPnEWB2gih33sRt9UGMHilmivO9UQw6jIG3U.lBWcxLPYcAVZVF5k7TO9LK82dbCQzBLpdJtxu8_xVBGFMYfFqfZxOSdJMQ~ee688bffd7088442835bbd7e1f3e8e9a

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

124.1 BDT

Average target price

168.3 BDT

Spread / Average Target

+35.64%

High Price Target

198 BDT

Spread / Highest target

+59.55%

Low Price Target

150 BDT

Spread / Lowest Target

+20.87%

Consensus detail

Consensus revision (last 18 months)

Ratings for Beximco Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar